{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:05:59Z","timestamp":1788415559386,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s42000-022-00411-9","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T07:03:27Z","timestamp":1666335807000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-8494","authenticated-orcid":false,"given":"Sara Lomelino","family":"Pinheiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-981X","authenticated-orcid":false,"given":"Joana","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-9791","authenticated-orcid":false,"given":"Daniela","family":"Cavaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1686-0163","authenticated-orcid":false,"given":"Ana Abrantes","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5181-669X","authenticated-orcid":false,"given":"In\u00eas Lemos","family":"Dam\u00e1sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8704-5292","authenticated-orcid":false,"given":"Sara","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9184-3617","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Passos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-5058","authenticated-orcid":false,"given":"Joana","family":"Sim\u00f5es-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"411_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152A:327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"411_CR2","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"411_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH (2014) Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13:834\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8","journal-title":"Lancet Neurol"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000369802","volume":"83","author":"C Bizzarri","year":"2015","unstructured":"Bizzarri C, Bottaro G (2015) Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr 83:232\u2013241. https:\/\/doi.org\/10.1159\/000369802","journal-title":"Horm Res Paediatr"},{"key":"411_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123:124\u2013133. https:\/\/doi.org\/10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"411_CR6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0660","volume":"143","author":"DT Miller","year":"2019","unstructured":"Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR et al (2019) Health supervision for children with neurofibromatosis type 1. Pediatrics 143:e20190660. https:\/\/doi.org\/10.1542\/peds.2019-0660","journal-title":"Pediatrics"},{"key":"411_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000458525","volume":"87","author":"I Sani","year":"2017","unstructured":"Sani I, Albanese A (2017) Endocrine long-term follow-up of children with neurofibromatosis type 1 and optic pathway glioma. Horm Res Paediatr 87:179\u2013188. https:\/\/doi.org\/10.1159\/000458525","journal-title":"Horm Res Paediatr"},{"key":"411_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","volume":"126","author":"R Habiby","year":"1995","unstructured":"Habiby R, Silverman B, Listernick R, Charrow J (1995) Precocious puberty in children with neurofibromatosis type 1. J Pediatr 126:364\u2013367. https:\/\/doi.org\/10.1016\/S0022-3476(95)70449-3","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"411_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1515\/JPEM.2000.13.S1.841","volume":"13","author":"R Virdis","year":"2000","unstructured":"Virdis R, Sigorini M, Laiolo A, Lorenzetti E, Street ME, Villani AR, Donadio A, Pisani F, Terzi C, Garavelli L (2000) Neurofibromatosis type 1 and precocious puberty. J Pediatr Endocrinol Metab 13(Suppl 1):841\u2013844. https:\/\/doi.org\/10.1515\/JPEM.2000.13.S1.841","journal-title":"J Pediatr Endocrinol Metab"},{"key":"411_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1542\/peds.100.4.667","volume":"100","author":"MH Cnossen","year":"1997","unstructured":"Cnossen MH, Stam EN, Cooiman LC, Simonsz HJ, Stroink H, Oranje AP, Halley DJ, de Goede-Bolder A, Niermeijer MF, de Muinck Keizer-Schrama SM (1997) Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. Pediatrics 100:667\u2013670. https:\/\/doi.org\/10.1542\/peds.100.4.667","journal-title":"Pediatrics"},{"key":"411_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/humupd\/7.3.292","volume":"7","author":"CJ Partsch","year":"2001","unstructured":"Partsch CJ, Sippell WG (2001) Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens. Hum Reprod Update 7:292\u2013302. https:\/\/doi.org\/10.1093\/humupd\/7.3.292","journal-title":"Hum Reprod Update"},{"key":"411_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1542\/peds.2005-0012","volume":"116","author":"G Teilmann","year":"2005","unstructured":"Teilmann G, Pedersen CB, Jensen TK, Skakkebaek NE, Juul A (2005) Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics 116:1323\u20131328. https:\/\/doi.org\/10.1542\/peds.2005-0012","journal-title":"Pediatrics"},{"key":"411_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00000441-199201000-00010","volume":"303","author":"DT Stein","year":"1992","unstructured":"Stein DT (1992) Southwestern Internal Medical Conference: new developments in the diagnosis and treatment of sexual precocity. Am J Med Sci 303:53\u201371. https:\/\/doi.org\/10.1097\/00000441-199201000-00010","journal-title":"Am J Med Sci"},{"key":"411_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14310\/horm.2002.1631","volume":"15","author":"E Bartolini","year":"2016","unstructured":"Bartolini E, Stagi S, Scalini P, Bianchi A, Ciccarone A, Mascalchi M (2016) Central precocious puberty due to hypothalamic hamartoma in neurofibromatosis type 1. Hormones 15:144\u2013146. https:\/\/doi.org\/10.14310\/horm.2002.1631","journal-title":"Hormones"},{"key":"411_CR15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23:1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"411_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","volume":"79","author":"HW Dodge","year":"1958","unstructured":"Dodge HW, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, Hayles AB (1958) Gliomas of the optic nerves. AMA Arch Neurol Psychiatry 79:607\u2013621. https:\/\/doi.org\/10.1001\/archneurpsyc.1958.02340060003001","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"411_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.6065\/apem.2040004.002","volume":"25","author":"SN Ab Rahim","year":"2020","unstructured":"Ab Rahim SN, Omar J, Tuan Ismail TS (2020) Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review. Ann Pediatr Endocrinol Metab 25:152\u2013155. https:\/\/doi.org\/10.6065\/apem.2040004.002","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"411_CR18","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1210\/jcem.86.9.7852","volume":"86","author":"L Lazar","year":"2001","unstructured":"Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R (2001) Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. J Clin Endocrinol Metab 86:4127\u20134132. https:\/\/doi.org\/10.1210\/jcem.86.9.7852","journal-title":"J Clin Endocrinol Metab"},{"key":"411_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/17512433.2018.1494569","volume":"11","author":"S Bertelloni","year":"2018","unstructured":"Bertelloni S, Mucaria C, Baroncelli GI, Peroni D (2018) Triptorelin depot for the treatment of children 2 years and older with central precocious puberty. Expert Rev Clin Pharmacol 11:659\u2013667. https:\/\/doi.org\/10.1080\/17512433.2018.1494569","journal-title":"Expert Rev Clin Pharmacol"},{"key":"411_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S2213-8587(15)00380-0","volume":"4","author":"AC Latronico","year":"2016","unstructured":"Latronico AC, Brito VC, Carel J (2016) Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol 4:265\u2013274. https:\/\/doi.org\/10.1016\/S2213-8587(15)00380-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"411_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0883073812446310","volume":"28","author":"EA Soucy","year":"2013","unstructured":"Soucy EA, van Oppen D, Nejedly NL, Gao F, Gutmann DH, Hollander AS (2013) Height assessments in children with neurofibromatosis type 1. J Child Neurol 28:303\u2013307. https:\/\/doi.org\/10.1177\/0883073812446310","journal-title":"J Child Neurol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-022-00411-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-022-00411-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T03:32:57Z","timestamp":1678764777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-022-00411-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1007\/s42000-022-00411-9","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional Ethics Committee and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not obtained from the patients, in accordance with appropriate ethics committee rules, since this was an observational retrospective study. The database was anonymized and data that could possibly identify the patients were eliminated. The study was approved be the institutional Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}